Navigation Links
Tuberculosis Immunotherapy Grant for Immunoxel Honibe Honey Lozenges
Date:2/3/2013

enty clinical trials involving more than 1,500 TB and AIDS patients. These studies have demonstrated that herbal extract taken along with conventional drugs can clear bacteria in 2-4 months instead of usual 6-24 months. While these results are clearly in favor of Immunoxel, they are not ideal, since the duration of therapy is not optimal and faster-acting regimens are still needed. In order to overcome this drawback four types of solid, sublingual formulations of Immunoxel were made and tested clinically to see if they performed better.

The most optimal delivery vehicle was Honibe honey lozenge currently sold for sore throat and nasal congestion relief. The new version of Immunoxel was developed jointly by two Canadian companies, Island Abbey Foods Ltd., and Immunitor Inc. The project was funded by earlier-issued CRDF grant which was successfully completed last year. The outcome of the clinical trial was published in Immunotherapy – a peer-reviewed journal from Future Medicine – a science publisher based in London, UK.

“It is a great honor for me personally and for our Canadian and Ukrainian partners to be among winners of the STEP grant” stated John Rowe, President of Island Abbey Foods Ltd. “We are very proud to be able to contribute to the global fight against TB”. Dr. Allen Bain, Director of Immunitor Inc, another company based in Charlottetown, PEI, and co-recipient of the grant added: "This success will help boost our fundraising efforts for expanded multinational trials and marketing in high TB burden countries in Africa and Asia. The ultimate Idea to Market goal endorsed by CRDF is thus fulfilled".

The anti-mycobacterial activity of honey has been known since ancient times and it is used as a folk medicine even today. Several in vitro studies demonstrated the direct inh
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vaccination reduces the risk of unvaccinated badger cubs testing tuberculosis positive
2. From the mouths of monkeys: Swab technique spots tuberculosis in non-human primates
3. Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant
4. Aeras and CNBG Sign Agreement on Tuberculosis Vaccine R&D
5. UroToday Launches New Prostate Cancer Focused Content Including Immunotherapy for Metastatic Castration-resistant Patients
6. Cancer Immunotherapy Expert Joins Pacific Meso Center Research Team
7. Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC)
8. OsteoVantage™ Receives Grant from the National Science Foundation
9. Boyd Coatings Awarded Workforce Training Grant
10. Hadasit Bio-Holdings Ltd. Portfolio Companies - ProtAb Ltd. and KAHR Medical Ltd. to Receive NIS 10.7 Million (Over $2.8 Million USD) in Additional Government Grants
11. University of Minnesota awarded $28 million grant to lead microelectronics development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), ... development of autologous cell therapies, announced today the publication ... in conjunction with co-authors from Kyoto University and the ... ongoing clinical research using dermal sheath cup (DSC) cells ... The paper entitled " Hair Follicle Dermal Stem Cells ...
(Date:12/22/2014)... 2014 The American Journal ... original research, reviews and editorials addressing developments and ... today published a provocative article exploring the role ... and potential treatment of prostate cancer. , ... proposes the possibility that there could be a ...
(Date:12/19/2014)... Charm Sciences is pleased to announce that its ... M1 in raw commingled milk is the first lateral ... peer reviewed report of the validation by Technology and ... Fisheries Research (ILVO-T&V) has been published by the Taylor ... toxic aflatoxin and a known carcinogen, can be passed ...
(Date:12/19/2014)... CITY, Calif. , Dec. 19, 2014 Bina ... , USA) announced today that they have been acquired ... 1,2 is a privately held company that provides ... of next generation sequencing (NGS) data for the academic ... the Roche Sequencing Unit, and will continue to focus ...
Breaking Biology Technology:Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... image of the carotid arteries that supply blood to the ... of Michigan Health System are using the system to diagnose ... Wire. Milwaukee GE Healthcare ... give physicians a non-invasive view of the heart and blood ...
... Finance Committee rejected Governor Jim Doyle's proposal for a 5 ... a plan to charge consumers for their music, book, art, ... turned down by the budget review panel. , ,After much ... entertainment called by some detractors the "iPod tax" ...
... your card in an ATM in San Francisco, the system ... But if you find yourself in an emergency room you'll ... series of tests because your medical record is a piece ... technology baffles users with ever-growing capabilities, including instant global transfer ...
Cached Biology Technology:GE Healthcare launches new medical scanner, places another in hospitals 2GE Healthcare launches new medical scanner, places another in hospitals 3Finance Committee rejects extra tax on Internet buys 2Finance Committee rejects extra tax on Internet buys 3Physician mindset slows adoption of electronic health records 2Physician mindset slows adoption of electronic health records 3Physician mindset slows adoption of electronic health records 4
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition of the ... to their offering. One major ... of multimodal biometric systems. Multimodal biometric systems utilize ... verification and identification purposes. This helps to reduce ...
(Date:12/11/2014)... 10, 2014  Data Sciences International (DSI), the ... a new series of digital telemetry implants to ... M series, part of the PhysioTel™ Digital platform, ... possible physiologic data when incorporating functional endpoints into ... to toxicology studies has evolved from short ECG ...
(Date:12/10/2014)... 9, 2014  Valencell, a leader in performance biometric ... staggering demand from its licensees for highly accurate, clinically ... not solely coming from fitness and health sectors, but ... "A wearable is only as useful as the biometric ... ultimate driver in long-term mass consumer adoption of wearable ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... cancer,has been announced by Agilent Technologies. The company ... advance of microarray-based,comparative genomic studies in cancer. According ... issue of the Proceedings of the,National Academy of ... Research Institute, Agilent has developed a specialised,microarray platform ...
... in life science and drug development : only "lucrative","markets" ... very promising drugs candidates or related research get canned,because ... if millions would have,been saved worldwide. The usual strategy ... that affect a "profitable" disease in addition to the,"non-profitable" ...
... "nano" - cancer detection using nanoparticles and MRI (magnetic ... one of the most important parts of the,work up ... the most appropriate treatment. And an essential part of ... been lymphatic spread. Current,methods include surgical removal of nodes ...
Cached Biology News:Breakthrough Microarray-based Technology for the Study of Cancer 2Finding Cures For Tropical Diseases: Is Open Source An Answer? 2Imaging Lymph Nodes with Nanoparticles 2
... 2D polyacrylamide gel electrophoresis (2D-PAGE) with biological ... core technology platform for proteomic analysis. 2D-PAGE ... samples limited only in the dynamic range ... proteins. Quantitative image based analysis of separated ...
... recombinant 177 amino acid polypeptide sequence corresponding ... MT1-MMP. Produced by activation of a ... E. coli periplasm. SPECIFIC ACTIVITY:The specific ... 140 mU/mg, where 1 U is the ...
Human interferon-beta (IFN-beta). Recognizes amino acids 30-47 of IFN-beta. No cross-reactivity with Human IFN-alpha or IFN-gamma....
Acetate Plate Sealers 100/Box...
Biology Products: